Phase II study of erlotinib in advanced non–small-cell lung cancer after failure of gefitinib

BC Cho, CK Im, MS Park, SK Kim, J Chang… - Journal of clinical …, 2007 - ascopubs.org
Purpose This study was designed to evaluate the efficacy and toxicity of erlotinib in patients
with advanced non–small-cell lung cancer (NSCLC) who experienced disease progression …
被引用次数：177 相关文章

Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib

CC Byoung, CK Im, MS Park, KK Se… - Journal of Clinical …, 2007 - yonsei.elsevierpure.com
Purpose: This study was designed to evaluate the efficacy and toxicity of erlotinib in patients
with advanced non-small-cell lung cancer (NSCLC) who experienced disease progression …
[PDF] psu.edu

[PDF][PDF] Phase II Study of Erlotinib in Advanced Non–Small-Cell Lung Cancer After Failure of Gefitinib

BC Cho, CK Im, MS Park, SK Kim, J Chang, JP Park… - J Clin Oncol, 2007 - Citeseer
Phase II Study of Erlotinib in Advanced Non–Small-Cell Lung Cancer After Failure of Gefitinib
Page 1 Phase II Study of Erlotinib in Advanced Non–Small-Cell Lung Cancer After Failure of …

Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib.

BC Cho, CK Im, MS Park, SK Kim, J Chang… - Journal of Clinical …, 2007 - europepmc.org
Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

Phase II Study of Erlotinib in Advanced Non–Small-Cell Lung Cancer After Failure of Gefitinib

BC Cho, CK Im, MS Park, SK Kim, J Chang… - Journal of Clinical …, 2007 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> This study was designed to
evaluate the efficacy and toxicity of erlotinib in patients with advanced non–small-cell lung …

[引用][C] Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib

BC CHO, CK IM, H KIM, JOOH KIM… - Journal of clinical …, 2007 - pascal-francis.inist.fr
Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …

Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib

BC Cho, CK Im, MS Park, SK Kim… - Journal of clinical …, 2007 - pubmed.ncbi.nlm.nih.gov
Purpose This study was designed to evaluate the efficacy and toxicity of erlotinib in patients
with advanced non-small-cell lung cancer (NSCLC) who experienced disease progression …

[引用][C] Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib

CHO BC - J Clin Oncol., 2007 - cir.nii.ac.jp
Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

[引用][C] Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib

BC CHO, CK IM, MS PARK… - Journal of …, 2007 - American Society of Clinical …